About IMCI Pharmaceuticals

Who We Are?

IMCI is a pharmaceutical company that develops cannabis-based medicines to treat neuropathic pain.

To assume its vision at an affordable price, IMCI operates a full value-chain of pharmaceutical cannabis-based production under SA & EU-GMP standards from seed to final product.


IMCI R&D is based in Israel while its operation locates in South Africa and target the African and the EU markets.

Vertically-Integrated Operation

Full value chain from Seed to Final product


Our Vision

To become a leading pharmaceutical company in the African continent, who will develop pharmaceutical cannabis-based novel medicines and medical pharma-grade products to treat neuropathic pain in prevalent health conditions at an affordable price.


Contact Us

We welcome questions regarding our company.
You can reach us by filling out the contact form below or through email.

Main Office: Keizersgracht 391 A, 1016 Amsterdam, Netherland

Regional Offices:

Israel: Gan Yavne, Israel

South Africa: Johannesburg, South Africa

  • LinkedIn

© 2020 by IMCI Pharmaceuticals